Market Highlights: Galectin Therapeutics Inc (GALT) Ends on a High Note at 2.26

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Galectin Therapeutics Inc (NASDAQ: GALT) closed at $2.26 in the last session, up 2.73% from day before closing price of $2.20. In other words, the price has increased by $2.73 from its previous closing price. On the day, 2.42 million shares were traded. GALT stock price reached its highest trading level at $2.39 during the session, while it also had its lowest trading level at $2.17.

Ratios:

We take a closer look at GALT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.02 and its Current Ratio is at 2.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 13, 2020, Reiterated its Buy rating but revised its target price to $12 from $9 previously.

On February 13, 2019, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $11.

H.C. Wainwright reiterated its Buy rating for the stock on December 07, 2017, while the target price for the stock was revised from $6 to $10.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 20 ’24 when FREEMAN KEVIN D bought 2,500 shares for $2.38 per share. The transaction valued at 5,950 led to the insider holds 28,469 shares of the business.

Zordani Richard A. Jr. bought 1,000 shares of GALT for $3,520 on Apr 30 ’24. The Director now owns 1,000 shares after completing the transaction at $3.52 per share. On Apr 24 ’24, another insider, LEWIS JOEL, who serves as the President and CEO of the company, bought 1,000 shares for $3.39 each. As a result, the insider paid 3,390 and bolstered with 2,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GALT now has a Market Capitalization of 140454704 and an Enterprise Value of 203513776.

Stock Price History:

Over the past 52 weeks, GALT has reached a high of $4.27, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is -23.45%, while the 200-Day Moving Average is calculated to be -0.13%.

Shares Statistics:

According to the various share statistics, GALT traded on average about 198.67K shares per day over the past 3-months and 380670 shares per day over the past 10 days. A total of 61.85M shares are outstanding, with a floating share count of 42.71M. Insiders hold about 31.27% of the company’s shares, while institutions hold 12.26% stake in the company. Shares short for GALT as of 1718323200 were 3945001 with a Short Ratio of 19.86, compared to 1715731200 on 3725760. Therefore, it implies a Short% of Shares Outstanding of 3945001 and a Short% of Float of 13.22.

Most Popular